These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 37368941)

  • 1. The effect of statins on mortality and cardiovascular disease in primary care hypertensive patients without other cardiovascular disease or diabetes.
    Andersson T; Nåtman J; Mourtzinis G; Bager JE; Bengtsson Boström K; Franzén S; Hjerpe P
    Eur J Prev Cardiol; 2023 Nov; 30(17):1883-1894. PubMed ID: 37368941
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of statin use in older people primary prevention group with risk of cardiovascular events and mortality: a systematic review and meta-analysis of observational studies.
    Awad K; Mohammed M; Zaki MM; Abushouk AI; Lip GYH; Blaha MJ; Lavie CJ; Toth PP; Jukema JW; Sattar N; Banach M;
    BMC Med; 2021 Jun; 19(1):139. PubMed ID: 34154589
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis.
    Palmer SC; Navaneethan SD; Craig JC; Johnson DW; Perkovic V; Hegbrant J; Strippoli GF
    Cochrane Database Syst Rev; 2014 May; (5):CD007784. PubMed ID: 24880031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fenofibrate's impact on cardiovascular risk in patients with diabetes: a nationwide propensity-score matched cohort study.
    Hong S; Kim KS; Han K; Park CY
    Cardiovasc Diabetol; 2024 Jul; 23(1):263. PubMed ID: 39026240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins, risk of diabetes, and implications on outcomes in the general population.
    Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
    J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low use of statins for secondary prevention in primary care: a survey in a northern Swedish population.
    Nilsson G; Samuelsson E; Söderström L; Mooe T
    BMC Fam Pract; 2016 Aug; 17(1):110. PubMed ID: 27515746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCSK9 inhibitors and ezetimibe with or without statin therapy for cardiovascular risk reduction: a systematic review and network meta-analysis.
    Khan SU; Yedlapati SH; Lone AN; Hao Q; Guyatt G; Delvaux N; Bekkering GET; Vandvik PO; Riaz IB; Li S; Aertgeerts B; Rodondi N
    BMJ; 2022 May; 377():e069116. PubMed ID: 35508321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Cantor A; Dana T; Wagner J; Ahmed AY; Fu R; Ferencik M
    JAMA; 2022 Aug; 328(8):754-771. PubMed ID: 35997724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Statin use and the risk of CVD events, stroke, and all-cause mortality in patients with diabetes: A systematic review and meta-analysis.
    Yang XH; Zhang BL; Cheng Y; Fu SK; Jin HM
    Nutr Metab Cardiovasc Dis; 2022 Nov; 32(11):2470-2482. PubMed ID: 36064686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Statin use and cardiovascular risk factors in diabetic patients developing a first myocardial infarction.
    Mortensen MB; Kulenovic I; Falk E
    Cardiovasc Diabetol; 2016 May; 15():81. PubMed ID: 27229923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statins for Primary Prevention of Cardiovascular Events and Mortality in Older Men.
    Orkaby AR; Gaziano JM; Djousse L; Driver JA
    J Am Geriatr Soc; 2017 Nov; 65(11):2362-2368. PubMed ID: 28892121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statins for primary prevention in adults aged 75 years and older: A nationwide population-based case-control study.
    Jun JE; Cho IJ; Han K; Jeong IK; Ahn KJ; Chung HY; Hwang YC
    Atherosclerosis; 2019 Apr; 283():28-34. PubMed ID: 30772771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A systematic review and economic evaluation of statins for the prevention of coronary events.
    Ward S; Lloyd Jones M; Pandor A; Holmes M; Ara R; Ryan A; Yeo W; Payne N
    Health Technol Assess; 2007 Apr; 11(14):1-160, iii-iv. PubMed ID: 17408535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study.
    Cho Y; Jeong Y; Seo DH; Ahn SH; Hong S; Suh YJ; Kim SH
    Atherosclerosis; 2021 Jul; 328():92-99. PubMed ID: 34126505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data.
    Figtree GA; Vernon ST; Hadziosmanovic N; Sundström J; Alfredsson J; Arnott C; Delatour V; Leósdóttir M; Hagström E
    Lancet; 2021 Mar; 397(10279):1085-1094. PubMed ID: 33711294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statins and atherosclerotic cardiovascular outcomes in patients on incident dialysis and with atherosclerotic heart disease.
    Shavadia JS; Wilson J; Edmonston D; Platt A; Ephraim P; Hall R; Goldstein BA; Boulware LE; Peterson E; Pendergast J; Scialla JJ
    Am Heart J; 2021 Jan; 231():36-44. PubMed ID: 33096103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins After Myocardial Infarction in the Oldest: A Cohort Study in the Clinical Practice Research Datalink Database.
    Lefeber GJ; Koek HL; Souverein PC; Bouvy ML; de Boer A; Knol W
    J Am Geriatr Soc; 2020 Feb; 68(2):329-336. PubMed ID: 31647578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Statins for Prevention of Cardiovascular Disease in Adults: Evidence Report and Systematic Review for the US Preventive Services Task Force.
    Chou R; Dana T; Blazina I; Daeges M; Jeanne TL
    JAMA; 2016 Nov; 316(19):2008-2024. PubMed ID: 27838722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacological management of modifiable cardiovascular risk factors (blood pressure and lipids) following diagnosis of myocardial infarction, stroke and diabetes: comparison between population-based studies in Russia and Norway.
    Cook S; Hopstock LA; Eggen AE; Bates K; Iakunchykova O; Kontsevaya A; McKee M; Schirmer H; Voevoda M; Kudryavtsev AV; Malyutina S; Leon DA
    BMC Cardiovasc Disord; 2020 May; 20(1):234. PubMed ID: 32430002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Outcomes of Population-Based Pharmacy Outreach to Increase Statin Use for Prevention of Cardiovascular Disease in Patients with Diabetes.
    Grembowski D; Ralston JD; Anderson ML
    J Manag Care Spec Pharm; 2016 Aug; 22(8):909-17. PubMed ID: 27459653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.